Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Drug Firms Under IRS Scrutiny For Offshore Income Shifting

Executive Summary

U.S.-based drug companies inappropriately reported that foreign profits accounted for 66% of their worldwide profits in 2003-2005, 23% more than the amount calculated by Tax Analysts, according to a publication by the non-profit group
Advertisement

Related Content

Merck settles with IRS
Merck settles with IRS
IRS Hopes GSK’s $3.4 Bil. Transfer Pricing Settlement Is Just The Beginning
IRS Hopes GSK’s $3.4 Bil. Transfer Pricing Settlement Is Just The Beginning
Patent Placement Can Impact Compound Value; Is Pfizer Finding Irish Gold?
Patent Placement Can Impact Compound Value; Is Pfizer Finding Irish Gold?
GSK Contests $5.2 Bil. Tax Bill After IRS Decision On Zantac Transfer Pricing
Advertisement
UsernamePublicRestriction

Register

PS047480

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel